Literature DB >> 5438766

Renal calculi.

E R Yendt.   

Abstract

The pathogenesis of renal calculi is reviewed in general terms followed by the results of investigation of 439 patients with renal calculi studied by the author at Toronto General Hospital over a 13-year period. Abnormalities of probable pathogenetic significance were encountered in 76% of patients. Idiopathic hypercalciuria was encountered in 42% of patients, primary hyperparathyroidism in 11%, urinary infection in 8% and miscellaneous disorders in 8%. The incidence of uric acid stones and cystinuria was 5% and 2% respectively. In the remaining 24% of patients in whom no definite abnormalities were encountered the mean urinary magnesium excretion was less than normal. Of 180 patients with idiopathic hypercalciuria, only 24 were females. In the diagnosis of hyperparathyroidism, the importance of detecting minimal degrees of hypercalcemia is stressed; attention is also drawn to the new observation that the upper limit of normal for serum calcium is slightly lower in females than in males. The efficacy of various measures advocated for the prevention of renal calculi is also reviewed. In the author's experience the administration of thiazides has been particularly effective in the prevention of calcium stones. Thiazides cause a sustained reduction in urinary calcium excretion and increase in urinary magnesium excretion. These agents also appear to affect the skeleton by diminishing bone resorption and slowing down bone turnover.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5438766      PMCID: PMC1946599     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  SOME CONCEPTS CONCERNING THE GENESIS OF URINARY CALCULI.

Authors:  W C THOMAS; E D BIRD; A TOMITA
Journal:  J Urol       Date:  1963-11       Impact factor: 7.450

2.  EFFECT OF ORTHOPHOSPHATE ON URINARY PYROPHOSPHATE EXCRETION AND THE PREVENTION OF UROLITHIASIS.

Authors:  H FLEISCH; S BISAZ; A D CARE
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

3.  EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.

Authors:  F W LAFFERTY; G E SPENCER; O H PEARSON
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

4.  New type of urinary calculus caused by antacid therapy.

Authors:  J R HERMAN; A S GOLDBERG
Journal:  JAMA       Date:  1960-10-29       Impact factor: 56.272

5.  Composition and structure of urinary stone.

Authors:  E L Prien; E L Prien
Journal:  Am J Med       Date:  1968-11       Impact factor: 4.965

6.  Pyrophosphate and the mineralizing potential of urine.

Authors:  A M Lewis; W C Thomas; A Tomita
Journal:  Clin Sci       Date:  1966-06       Impact factor: 6.124

Review 7.  Skeletal renewal and metabolic bone disease.

Authors:  W H Harris; R P Heaney
Journal:  N Engl J Med       Date:  1969-01-30       Impact factor: 91.245

Review 8.  Cystinuria.

Authors:  J C Crawhall; R W Watts
Journal:  Am J Med       Date:  1968-11       Impact factor: 4.965

9.  Control of crystallization in urine.

Authors:  J E Howard; W C Thomas
Journal:  Am J Med       Date:  1968-11       Impact factor: 4.965

10.  The effects of thiazides in idiopathic hypercalciuria.

Authors:  E R Yendt; R J Gagné; M Cohanim
Journal:  Am J Med Sci       Date:  1966-04       Impact factor: 2.378

View more
  15 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  The influence of calcium content of water, intake of vegetables and fruit and of other food factors upon the incidence of renal calculi.

Authors:  G A Rose; E J Westbury
Journal:  Urol Res       Date:  1975-08-08

Review 3.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

4.  Renal stones and their medical management.

Authors:  E K Smith
Journal:  Can Fam Physician       Date:  1978-08       Impact factor: 3.275

5.  Ionised calcium levels in "normocalcaemic" hyperparathyroidism.

Authors:  F P Muldowney; R Freaney; E A Spillane; P O'Donohoe
Journal:  Ir J Med Sci       Date:  1973-09       Impact factor: 1.568

6.  Allopurinol treatment for calcium stone disease.

Authors: 
Journal:  Br Med J       Date:  1977-11-19

7.  Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.

Authors:  F L Coe; J M Canterbury; J J Firpo; E Reiss
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

8.  The effect of verapamil and thiazide in the prevention of renal stone formation.

Authors:  A Halabe; N L Wong; R A Sutton
Journal:  Urol Res       Date:  1990

9.  The use of thiazides in the prevention of renal calculi.

Authors:  E R Yendt; G F Guay; D A Garcia
Journal:  Can Med Assoc J       Date:  1970-03-28       Impact factor: 8.262

10.  Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.

Authors:  D R Wilson; G Pylypchuk; U Ehrig
Journal:  Can Med Assoc J       Date:  1979-03-17       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.